Most importantly, the resistance of tumor cells to hypoxia-induced apoptosis in late stages is very strong and the new regulatory mechanism mentioned above indicates that the upregulation of HSPA2 may enhance the resistance of tumor cells to hypoxia-induced apoptosis. The gene discussed is HSPA2; the disease is neoplasm.